Letters
Drug company influence
Smoking cessation is better than drugs for mild COPD
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2152 (Published 14 May 2019) Cite this as: BMJ 2019;365:l2152
- Stephen Head, retired clinical director
- Newark NG22 9JU, UK
- shead{at}doctors.org.uk
Salisbury writes about an integrated multidisciplinary respiratory team in Oxford jointly funded by a drug company and the local clinical commissioning group (CCG).1
We had a similar initiative locally. In short, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.